search

Active clinical trials for "Urination Disorders"

Results 1-10 of 13

Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy...

Urinary IncontinenceDaytime Wetting8 more

The aim of this study is to investigate whether the activity in brain areas controlling the bladder is different among children suffering from Overactive Bladder (OAB) and Daytime Urinary Incontinence (DUI) compared to age- and gender-matched healthy children without bladder symptoms. Moreover, the aim is to investigate if sacral transcutaneous electric nerve stimulation (TENS) has a central mechanism of action. Children with OAB and DUI will be recruited from involved pediatric departments, and functional magnetic resonance imaging (fMRI) will be performed before and after 10 weeks of sacral TENS. In healthy children without bladder symptoms, only the baseline fMRI will be performed.

Recruiting17 enrollment criteria

Registry for Patients Undergoing AUS Surgery for Female SUI Due to ISD

Urinary IncontinenceUrinary Incontinence4 more

Prospective collection of pre-defined parameters of AUS Surgery for Female Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency

Recruiting5 enrollment criteria

Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders...

Urination Disorders

To investigate pharmacokinetics, safety, and tolerability of tamsulosin hydrochloride in children with voiding disorders

Completed19 enrollment criteria

Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery

Urinary IncontinenceStress4 more

To study the safety and potential efficacy of Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR) for the treatment of male stress urinary incontinence (SUI) for patients that have undergone prior prostate surgery.

Completed12 enrollment criteria

An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and...

Urination Disorders

The purpose of this study is to evaluate the safety and effectiveness of oxybutynin extended release tablets 10 mg plus tamsulosin HCl 0.4 mg in the treatment of lower urinary tract symptoms as measured by change of the total International Prostate Symptom Score (I-PSS) from baseline to Week 12 or the Final Visit.

Completed11 enrollment criteria

Prevalence, Etiology and Therapy of Micturition Disorders of Children With a Mental and/or Motoric...

Micturition Disorder

Investigation of the prevalence etiology and therapy of micturition disorders of children with a mental and/or motoric disability

Completed3 enrollment criteria

Impact Evaluation of Different Micturition Modes on Patients With Medullar Injury of Quality of...

Medullary InjuryMicturition Disorder

The primary objective of the study is to analysis the personal determination factors (age, sex, stage of injury, pain, urinary continence and durations of spinal cord injury) and environmental determination factors (need for medical devices, nurse care and adaptation of accommodations) which affect the quality of life and their occupations on patients with medullar injury.

Active9 enrollment criteria

Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to...

Overactive BladderPostmenopausal Disorder1 more

This study is a multi-site, randomized, opened and parallel-controlled clinical study. The patients up to the inclusion criteria are randomly treated with Solifenacin Succinate Tablets (5mg/d) or Solifenacin Succinate Tablets (5mg/d) + local estrogen for 12 weeks. Before the dosing and at Week 4, 8 and 12 of the dosing, various examinations are made, and various indices are evaluated.

Completed17 enrollment criteria

Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal...

Paroxysmal Nocturnal HemoglobinuriaHemoglobinuria9 more

Paroxysmal nocturnal hemoglobinuria is an acquired chronic hemolytic anemia,this study is designed to evaluate the safety and efficacy of Levamisole combined with cyclosporine A in patients with Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the setting of another bone marrow failure syndromes

Unknown status7 enrollment criteria

Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal...

Paroxysmal Nocturnal HemoglobinuriaHemoglobinuria9 more

Paroxysmal nocturnal hemoglobinuria is an acquired chronic hemolytic anemia,this study is designed to evaluate the safety and efficacy of Levamisole combined with cyclosporine A in patients with classic paroxysmal nocturnal hemoglobinuria.

Unknown status8 enrollment criteria
12

Need Help? Contact our team!


We'll reach out to this number within 24 hrs